Location History:
- Kirkland, CA (2006 - 2010)
- Belle Mead, NJ (US) (2011)
Company Filing History:
2 out of 10 
1 out of 28 
1 out of 1 Years Active: 2006-2011
Title: The Innovations of Xicai Huang
Introduction
Xicai Huang is a notable inventor based in Kirkland, CA. He has made significant contributions to the field of biotechnology, particularly in the development of anti-obesity and anti-angiogenic agents. With a total of 4 patents to his name, Huang's work has the potential to impact health and medical treatments significantly.
Latest Patents
Huang's latest patents include innovative compounds aimed at addressing obesity and angiogenesis. One of his key inventions is related to anti-obesity agents, which involves a compound comprising a PYY peptide or a functional derivative that is coupled to a reactive group. This reactive group can form a stable covalent bond with a blood component, enhancing the anti-obesity activity of the peptide in patients. Another significant patent focuses on long-lasting anti-angiogenic peptides. These modified peptides can form a peptidase-stabilized anti-angiogenic peptide, particularly modified kringle 5 peptides, which can create a conjugate with a blood protein. These conjugates can be administered to patients to provide an anti-angiogenic effect, showcasing Huang's innovative approach to medical challenges.
Career Highlights
Throughout his career, Xicai Huang has worked with various companies, including Conjuchem Biotechnologies Inc. and Conjuchem, Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in biotechnology.
Collaborations
Huang has collaborated with notable professionals in his field, including Karen Thibaudeau and Dominique Bridon. These collaborations have likely enriched his research and development efforts, leading to the successful creation of his patented innovations.
Conclusion
Xicai Huang's contributions to biotechnology through his patents reflect his dedication to addressing significant health issues. His innovative work in anti-obesity and anti-angiogenic agents demonstrates the potential for scientific advancements to improve patient outcomes.